SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-038230
Filing Date
2023-11-09
Accepted
2023-11-09 16:08:53
Documents
48
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q advm-20230930.htm   iXBRL 10-Q 1124083
2 EX-31.1 advm-20230930ex311.htm EX-31.1 10088
3 EX-31.2 advm-20230930ex312.htm EX-31.2 10109
4 EX-32.1 advm-20230930ex321.htm EX-32.1 5351
5 EX-32.2 advm-20230930ex322.htm EX-32.2 5148
  Complete submission text file 0001628280-23-038230.txt   4111094

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20230930.xsd EX-101.SCH 21805
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT advm-20230930_cal.xml EX-101.CAL 58001
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT advm-20230930_def.xml EX-101.DEF 77957
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20230930_lab.xml EX-101.LAB 354615
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20230930_pre.xml EX-101.PRE 209825
42 EXTRACTED XBRL INSTANCE DOCUMENT advm-20230930_htm.xml XML 434480
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36579 | Film No.: 231392418
SIC: 2836 Biological Products, (No Diagnostic Substances)